Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02070315 · ClinicalTrials.gov registry record
Quantitative Evaluation of the Progression of Liver Disease, Using ShearWaveTM
A clinical trial of Heart Failure and Liver Disease, sponsored by Baylor Research Institute.
- Completed
- Registry status
- 1,247
- Enrollment target
- 1
- Study location
NCT02070315: Completed study of Heart Failure and Liver Disease, sponsored by Baylor Research Institute.
NCT02070315 is a study of Heart Failure and Liver Disease that has completed, run by Baylor Research Institute. The registered enrollment target is 1,247 participants, below the 2,046-participant average among 397 other Heart Failure trials with a reported enrollment target (39% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02070315, a study of Heart Failure and Liver Disease, has completed, sponsored by Baylor Research Institute.
- COMPLETED
- Registry status
- 1,247 participants
- Enrollment target
- 1
- Study location
Study Summary
Liver biopsy for the assessment of fibrosis has multiple limitations. Liver ShearWaveTM Elastography may provide a non-invasive, fast, and reproducible alternative for the quantitative assessment of liver fibrosis.
Primary Outcome
Patients will have a scan performed at their regularly scheduled clinic visits.
Conditions Studied
Study Locations (1)
Texas
- Baylor University Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,247 participants |
| Start Date | 2012-02 |
| Est. Completion | 2022-04-28 |
What the finished NCT02070315 record still lists
NCT02070315 is an observational study that tracks outcomes without assigning an intervention. Its 1,247 participants enrollment target places it among the larger protocols in the corpus, below the 2,046-participant average among 397 other Heart Failure trials with a reported enrollment target (39% lower).
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.
NCT02070315 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02070315 about?
NCT02070315 is a clinical study titled "Quantitative Evaluation of the Progression of Liver Disease, Using ShearWaveTM". Liver biopsy for the assessment of fibrosis has multiple limitations. Liver ShearWaveTM Elastography may provide a non-invasive, fast, and reproducible alternative for the quantitative assessment of liver fibrosis.
What is the current status of trial NCT02070315?
This trial is currently completed. The enrollment target is 1,247 participants. The study started on 2012-02. Estimated completion is 2022-04-28.
What conditions does trial NCT02070315 study?
This clinical trial studies the following conditions: Heart Failure, Liver Disease.
Who is sponsoring clinical trial NCT02070315?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02070315 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02070315's enrollment target sits among peer trials
1,247 62nd of 397 higher than 336 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02743858 · 1,250 participants
Lymphedema Surveillance Study
- NCT04670874 · 1,250 participants
Quality of Life in Cutaneous Lymphoma Patients Using the Skindex29
- NCT04807868 · 1,250 participants
AdventHealth Research Institute Non-Alcoholic Fatty Liver Disease Biobank and Registry (AVAIL)
- NCT05995821 · 1,250 participants
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia